Comments
Array shares rise on lung cancer, melanoma results
17.05.2012. | (Reuters) - Array BioPharma Inc's experimental lung cancer drug, selumetinib, w as shown to increase survival by an additional 4.2 months over chemotherapy alone, according to new data released on Wednesday....
